IMPACT, NCT00806234: Reducing Weight Gain and Improving Metabolic Function in Children Being Treated With Antipsychotics |
|
|
| Completed | 4 | 127 | US | Aripiprazole or Perphenazine, Abilify, Trilafon, Metformin, Glucophage, Olanzapine, quetiapine, risperidone, ziprasidone, aripiprazole, asenapine, iloperidone, lurasidone, paliperidone, or olanzapine/fluoxetine, Zyprexa, Seroquel, Risperdal, Geodon, Abilify, Saphris, Sycrest, Fanapt, Fanapta, Zomaril, Latuda, Invega, Symbyax | Johns Hopkins University, National Institute of Mental Health (NIMH), University of Maryland, University of North Carolina, Chapel Hill, The Zucker Hillside Hospital | Psychotic Disorders | 03/14 | 03/14 | | |
NCT02307396: Evaluation of the Necessity of Long-term Pharmacological Treatment With Antipsychotics in Schizophrenic Patients |
|
|
| Completed | 4 | 21 | Europe | Olanzapine, Amisulpride, Risperidone, Haloperidol, Quetiapine, Perphenazine, Sulpiride, bromperidol, Zuclopenthixol, Thioridazine, Paliperidone, Ziprasidone, Benperidol, Fluspirilene, Pimozide, Perazine, Fluphenazine, Flupentixole, Sertindole | Technische Universität München | Schizophrenia, Schizophrenia and Disorders With Psychotic Features, Schizoaffective Disorders | 06/16 | 06/16 | | |
